Vantive, formerly the Baxter Kidney Care segment, has officially launched as an independent company dedicated to vital organ therapies. With a 70-year legacy in kidney care innovation, Vantive remains committed to extending lives and expanding possibilities through advanced dialysis solutions, digital innovation, and critical care therapies.
As a standalone company, Vantive Thailand continues to deliver cutting-edge products and services for both home and in-clinic dialysis, as well as intensive care therapies supporting kidney and multi-organ health. With over 70,000 daily patient interactions in Thailand, Vantive plays a crucial role in the country’s healthcare landscape.
Recognising World Kidney Day
On World Kidney Day (13 March), Vantive reaffirms its commitment to supporting the millions of patients living with chronic and acute kidney disease. The global campaign aims to raise awareness of kidney health and reduce the impact of kidney-related diseases.
Mr. Paul Uthaichalanond, General Manager, Vantive (Malaysia, Thailand, Vietnam, Myanmar)
Paul Uthaichalanond, General Manager of Vantive (Malaysia, Thailand, Vietnam, Myanmar), stated: "The launch of Vantive is a major milestone for us as a local Thai medical manufacturer supporting dialysis patients across Thailand and Southeast Asia. As a standalone company, we are focused on investing in innovation, strengthening partnerships, and delivering solutions that address the evolving needs of kidney patients globally. Our commitment to World Kidney Day reflects our mission to empower patients and expand access to home dialysis therapies that meet their clinical needs."
Driving Innovation in Kidney Care
Vantive Thailand leads in telehealth solutions for kidney care and vital organ therapies, including:
- Sharesource Connectivity Platform – the first two-way remote patient management system for peritoneal dialysis (PD), improving care coordination.
- MyPD Application – a digital tool empowering patients and their care teams.
- PrisMax and PrismaLung+ Platforms – newly launched in Thailand, these critical care solutions support continuous renal replacement therapy (CRRT) and multi-organ therapies in ICUs.
Investing in Thailand’s Healthcare Future
Vantive’s dialysis manufacturing operations in the Eastern Economic Corridor (EEC) contribute approximately ฿2.1 billion annually to Thailand’s GDP, while generating 3,200 direct and indirect jobs. As part of its long-term commitment, Vantive will continue exploring opportunities for further investment in Thailand’s healthcare infrastructure.
Collaborating for Better Patient Outcomes
Vantive believes in the power of partnerships to advance kidney care. The company works closely with:
- The National Health Security Office (NHSO) and medical societies to drive best practices.
- Patient organisations to improve access to care.
- Private sector partners like SCGC to enhance sustainability.
Through initiatives like Green Nephrology and Run for Fund, Vantive reinforces its social responsibility and commitment to the Thai community.
With local investment, cutting-edge innovation, and strong partnerships, Vantive Thailand is transforming kidney care—one patient at a time.
